Dr. Reddy’s Laboratories Ltd has been listed as an Index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the Pharmaceuticals, Biotechnology & Life Sciences Industry Group. The Company has been recognized for its corporate sustainability leadership and is the only pharmaceutical company on the Index of Emerging Markets.

The listing was based on 22 criterion, with Dr. Reddy’s receiving high scores for Product Quality and Recall Management, Codes of Business Conduct, Environmental Reporting, Corporate Citizenship and Philanthropy.

G V Prasad, Co-Chairman and CEO, Dr. Reddy’s Laboratories said, ‘’Over the years, Dr. Reddy’s has evolved into a global organization built on the foundation of responsible business practices. This has earned us the trust and respect of all the stakeholders we serve. I see our inclusion in the Dow Jones Sustainability Indices as another validation of our commitment to sustainability in all aspects of our business.’’

The Dow Jones Sustainability Indices is the foremost global benchmark for corporate sustainability. DJSI tracks leading sustainability-driven companies based on the analysis of financially relevant environmental, social and governance factors.